Brain penetrable histone deacetylase 6 inhibitor SW-100 ameliorates memory and learning impairments in a mouse model of fragile X syndrome
Disease-modifying therapies are needed for Fragile X Syndrome (FXS), as at present there
are no effective treatments or cures. Herein, we report on a tetrahydroquinoline-based …
are no effective treatments or cures. Herein, we report on a tetrahydroquinoline-based …
Brain Penetrable Histone Deacetylase 6 Inhibitor SW-100 Ameliorates Memory and Learning Impairments in a Mouse Model of Fragile X Syndrome
AP Kozikowski, S Shen, M Pardo… - ACS chemical …, 2019 - scholarship.miami.edu
Abstract Memory-drug effects Histone Deacetylase 6-antagonists & inhibitors Learning-drug
effects Fragile X Syndrome-physiopathology Hippocampus-drug effects Cognition-drug …
effects Fragile X Syndrome-physiopathology Hippocampus-drug effects Cognition-drug …
[PDF][PDF] Brain Penetrable Histone Deacetylase 6 Inhibitor SW-100 Ameliorates Memory and Learning Impairments in a Mouse Model of Fragile X Syndrome
AP Kozikowski, S Shen, M Pardo, MT Tavares… - 2018 - lirias.kuleuven.be
Disease-modifying therapies are needed for Fragile X syndrome (FXS), as at present there
are no effective treatments or cures. Herein, we report on a tetrahydroquinoline-based …
are no effective treatments or cures. Herein, we report on a tetrahydroquinoline-based …
Brain Penetrable Histone Deacetylase 6 Inhibitor SW-100 Ameliorates Memory and Learning Impairments in a Mouse Model of Fragile X Syndrome
AP Kozikowski, S Shen, M Pardo… - ACS chemical …, 2019 - pubmed.ncbi.nlm.nih.gov
Disease-modifying therapies are needed for Fragile X Syndrome (FXS), as at present there
are no effective treatments or cures. Herein, we report on a tetrahydroquinoline-based …
are no effective treatments or cures. Herein, we report on a tetrahydroquinoline-based …
[HTML][HTML] Brain Penetrable Histone Deacetylase 6 Inhibitor SW-100 Ameliorates Memory and Learning Impairments in a Mouse Model of Fragile X Syndrome
AP Kozikowski, S Shen, M Pardo… - ACS chemical …, 2019 - ncbi.nlm.nih.gov
Disease-modifying therapies are needed for Fragile X Syndrome (FXS), as at present there
are no effective treatments or cures. Herein, we report on a tetrahydroquinoline-based …
are no effective treatments or cures. Herein, we report on a tetrahydroquinoline-based …
[引用][C] Brain Penetrable Histone Deacetylase 6 Inhibitor SW-100 Ameliorates Memory and Learning Impairments in a Mouse Model of Fragile X Syndrome
AP Kozikowski, S Shen, M Pardo, MT Tavares… - ACS Chemical …, 2018 - cir.nii.ac.jp
Brain Penetrable Histone Deacetylase 6 Inhibitor SW-100 Ameliorates Memory and Learning
Impairments in a Mouse Model of Fragile X Syndrome | CiNii Research CiNii 国立情報学研究所 …
Impairments in a Mouse Model of Fragile X Syndrome | CiNii Research CiNii 国立情報学研究所 …
Brain Penetrable Histone Deacetylase 6 Inhibitor SW-100 Ameliorates Memory and Learning Impairments in a Mouse Model of Fragile X Syndrome.
AP Kozikowski, S Shen, M Pardo… - ACS Chemical …, 2018 - europepmc.org
Disease-modifying therapies are needed for Fragile X Syndrome (FXS), as at present there
are no effective treatments or cures. Herein, we report on a tetrahydroquinoline-based …
are no effective treatments or cures. Herein, we report on a tetrahydroquinoline-based …